{ "cik": 1082554, "cik_padded": "0001082554", "entityName": "UNITED THERAPEUTICS Corp", "fiscal_years": [ { "accn": "0001082554-26-000006", "filed": "2026-02-25", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 1000000000.0, "capex": 520500000.0, "cash": 1557100000.0, "cost_of_revenue": 384400000.0, "eps_diluted": 27.86, "free_cash_flow": 1040700000.0, "gross_profit": 2798300000.0, "net_income": 1334700000.0, "operating_cash_flow": 1561200000.0, "operating_income": 1492500000.0, "revenue": 3182700000.0, "stockholders_equity": 7096200000.0, "total_assets": 7880000000.0, "total_liabilities": 783800000.0 }, "period_end": "2025-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.8792220441763283, "leverage": 0.11045348214537358, "net_margin": 0.41936091997360736, "operating_margin": 0.46894146479404275, "revenue_growth_yoy": 0.10610273163272399, "roa_avg2y": 0.17511151928627658, "roa_period_end": 0.16937817258883248, "roe_avg2y": 0.19714627553507333, "roe_period_end": 0.1880865815506891 } }, { "accn": "0001082554-26-000006", "filed": "2026-02-25", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 1000000000.0, "capex": 246500000.0, "cash": 1697200000.0, "cost_of_revenue": 309700000.0, "eps_diluted": 24.64, "free_cash_flow": 1080600000.0, "gross_profit": 2567700000.0, "net_income": 1195100000.0, "operating_cash_flow": 1327100000.0, "operating_income": 1377000000.0, "revenue": 2877400000.0, "stockholders_equity": 6444000000.0, "total_assets": 7364000000.0, "total_liabilities": 920000000.0 }, "period_end": "2024-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.8923681100993953, "leverage": 0.14276846679081315, "net_margin": 0.4153402377146035, "operating_margin": 0.4785570306526726, "revenue_growth_yoy": 0.23626208378088076, "roa_avg2y": 0.16448971165095314, "roa_period_end": 0.16228951656708313, "roe_avg2y": 0.19231140576725025, "roe_period_end": 0.18545934202358783 } }, { "accn": "0001082554-26-000006", "filed": "2026-02-25", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 230400000.0, "cash": 1207700000.0, "cost_of_revenue": 257500000.0, "eps_diluted": 19.81, "free_cash_flow": 747600000.0, "gross_profit": 2070000000.0, "net_income": 984800000.0, "operating_cash_flow": 978000000.0, "operating_income": 1184900000.0, "revenue": 2327500000.0, "stockholders_equity": 5984800000.0, "total_assets": 7167000000.0, "total_liabilities": 1182200000.0 }, "period_end": "2023-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.8893662728249194, "leverage": 0.1975337521721695, "net_margin": 0.4231149301825994, "operating_margin": 0.5090870032223416, "revenue_growth_yoy": 0.20203480865568352, "roa_avg2y": 0.14908223895848313, "roa_period_end": 0.13740756243895633, "roe_avg2y": 0.18268330009738903, "roe_period_end": 0.16455019382435507 } }, { "accn": "0001082554-26-000006", "filed": "2026-02-25", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 138800000.0, "cash": 961200000.0, "cost_of_revenue": 151600000.0, "eps_diluted": 15.0, "free_cash_flow": 663700000.0, "gross_profit": 1784700000.0, "net_income": 727300000.0, "operating_cash_flow": 802500000.0, "operating_income": 979700000.0, "revenue": 1936300000.0, "stockholders_equity": 4796700000.0, "total_assets": 6044500000.0, "total_liabilities": 1247800000.0 }, "period_end": "2022-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.9217063471569488, "leverage": 0.26013717764296285, "net_margin": 0.3756132830656406, "operating_margin": 0.5059649847647575, "revenue_growth_yoy": 0.14879857609018096, "roa_avg2y": 0.12971748590996646, "roa_period_end": 0.1203242617255356, "roe_avg2y": 0.16613367444835306, "roe_period_end": 0.15162507557278962 } }, { "accn": "0001082554-25-000005", "filed": "2025-02-26", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 120800000.0, "cash": 894800000.0, "cost_of_revenue": 122500000.0, "eps_diluted": 10.06, "free_cash_flow": 477400000.0, "gross_profit": 1563000000.0, "net_income": 475800000.0, "operating_cash_flow": 598200000.0, "operating_income": 555900000.0, "revenue": 1685500000.0, "stockholders_equity": 3958900000.0, "total_assets": 5169100000.0, "total_liabilities": 1210200000.0 }, "period_end": "2021-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.9273212696529219, "leverage": 0.30569097476571777, "net_margin": 0.2822901216256304, "operating_margin": 0.3298131118362504, "revenue_growth_yoy": 0.13631767006000134, "roa_avg2y": 0.09725983994439959, "roa_period_end": 0.0920469714263605, "roe_avg2y": 0.12939720700017676, "roe_period_end": 0.12018489984591679 } }, { "accn": "0001082554-24-000005", "filed": "2024-02-21", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 59300000.0, "cash": 738700000.0, "cost_of_revenue": 108100000.0, "eps_diluted": 11.54, "free_cash_flow": 696400000.0, "gross_profit": 1375200000.0, "operating_cash_flow": 755700000.0, "operating_income": 593600000.0, "revenue": 1483300000.0, "stockholders_equity": 3395200000.0, "total_assets": 4615000000.0, "total_liabilities": 1219800000.0 }, "period_end": "2020-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio" }, "ratios": { "gross_margin": 0.9271219577968044, "leverage": 0.35927191328934965, "operating_margin": 0.40018876828692773, "revenue_growth_yoy": 0.023812810601877416 } }, { "accn": "0001082554-23-000005", "filed": "2023-02-22", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 83700000.0, "cash": 738400000.0, "cost_of_revenue": 117600000.0, "eps_diluted": -2.39, "free_cash_flow": -290300000.0, "gross_profit": 1331200000.0, "operating_cash_flow": -206600000.0, "operating_income": -187600000.0, "revenue": 1448800000.0, "stockholders_equity": 2780400000.0, "total_assets": 3913400000.0, "total_liabilities": 1133000000.0 }, "period_end": "2019-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio" }, "ratios": { "gross_margin": 0.9188293760353395, "leverage": 0.4074953244137534, "operating_margin": -0.12948647156267257, "revenue_growth_yoy": -0.10996436908711144 } }, { "accn": "0001104659-20-025009", "filed": "2022-02-24", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 184400000.0, "cash": 669200000.0, "eps_diluted": 13.39, "free_cash_flow": 594000000.0, "operating_cash_flow": 778400000.0, "operating_income": 805400000.0, "revenue": 1627800000.0, "stockholders_equity": 2788600000.0, "total_assets": 3401000000.0, "total_liabilities": 593200000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio" }, "ratios": { "leverage": 0.21272323029477158, "operating_margin": 0.4947782282835729, "revenue_growth_yoy": -0.05651191097200487 } }, { "accn": "0001082554-21-000008", "filed": "2021-02-24", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 250000000.0, "capex": 86300000.0, "cash": 705100000.0, "eps_diluted": 9.31, "free_cash_flow": 387900000.0, "operating_cash_flow": 474200000.0, "operating_income": 814900000.0, "revenue": 1725300000.0, "stockholders_equity": 2101800000.0, "total_assets": 2879400000.0, "total_liabilities": 758400000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio" }, "ratios": { "leverage": 0.3608335712246646, "operating_margin": 0.4723236538573002, "revenue_growth_yoy": 0.07912184138103577 } }, { "accn": "0001104659-20-025009", "filed": "2020-02-26", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 500000000.0, "capex": 38000000.0, "cash": 1023000000.0, "eps_diluted": 15.25, "free_cash_flow": 605600000.0, "operating_cash_flow": 643600000.0, "operating_income": 1061700000.0, "revenue": 1598800000.0, "stockholders_equity": 1851300000.0, "total_assets": 2325600000.0, "total_liabilities": 463400000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "operating_margin": "ratio" }, "ratios": { "leverage": 0.25031059255658183, "operating_margin": 0.6640605454090569 } }, { "accn": "0001047469-18-000911", "filed": "2018-02-21", "fiscal_year": 2015, "form": "10-K", "fundamental_units": { "buybacks": "USD" }, "fundamentals": { "buybacks": 394500000.0 }, "period_end": "2015-12-31", "ratios": {} }, { "accn": "0001047469-17-000802", "filed": "2017-02-22", "fiscal_year": 2014, "form": "10-K", "fundamental_units": { "buybacks": "USD", "gross_profit": "USD" }, "fundamentals": { "buybacks": 483100000.0, "gross_profit": 1153650000.0 }, "period_end": "2014-12-31", "ratios": {} }, { "accn": "0001047469-16-010392", "filed": "2016-02-25", "fiscal_year": 2013, "form": "10-K", "fundamental_units": { "buybacks": "USD", "gross_profit": "USD" }, "fundamentals": { "buybacks": 42439000.0, "gross_profit": 975817000.0 }, "period_end": "2013-12-31", "ratios": {} }, { "accn": "0001047469-15-001069", "filed": "2015-02-24", "fiscal_year": 2012, "form": "10-K", "fundamental_units": { "buybacks": "USD", "gross_profit": "USD" }, "fundamentals": { "buybacks": 188000000.0, "gross_profit": 786826000.0 }, "period_end": "2012-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001082554-26-000006", "filed": "2026-02-25", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001082554.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001082554.json" }, "ticker": "UTHR" }